newsCPHI Pharma Awards 2023 finalists announced15 September 2023 | By CPhIThe finalists for CPHI’s Pharma Awards 2023 across twelve categories for innovation, manufacturing, sustainability, best start-up initiative and breakthrough digital technologies have been announced.
news$145 million pharma acquisition to help launch opioid overdose drug16 November 2022 | By Catherine Eckford (European Pharmaceutical Review)Indivior’s $145 million acquisition of Opiant Pharmaceuticals will support the launch of OPNT003, an opioid overdose reversal agent.
newsNumber of illegal diazepam tablets seized doubles in UK6 December 2019 | By Victoria Rees (European Pharmaceutical Review)The amount of illegal diazepam tablets commandeered at the border of the UK doubled last year, according to a report.
articleThe impact of counterfeit drugs in south and south-east Asia3 July 2019 | By Victoria Rees (European Pharmaceutical Review)Substandard and counterfeit drugs can negatively impact the pharmaceutical industry and patients. Here, we investigate counterfeits in south-east Asia and possible solutions.
newsInadequate FDA oversight concerning fentanyl prescriptions19 February 2019 | By European Pharmaceutical ReviewA study has found that the FDA failed to design and implement an effective monitoring program for Transmucosal Immediate-Release Fentanyls...
newsPrescribed opioids raise risk of pneumonia8 January 2019 | By European Pharmaceutical ReviewA study has found that opioids, including morphine, codeine and fentanyl increase the likelihood of patients being affected by pneumonia...
